Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical validation of dried blood spot testing for selected antipsychotics
NL-OMON28955Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of aripiprazole, risperidone, paliperidone and pipamperone in Schizophrenia Spectrum Disorders (SSD) (4 arms), sponsored by Erasmus MC. Primary endpoint: Agreement between DBS and venous plasma antipsychotic levels. Started Jun 2016; status: active, not recruiting.
02
Drugs
aripiprazolerisperidonepaliperidonepipamperone
03
Conditions
Schizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON28955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28955.